{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:59:09Z","timestamp":1792634349219,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Clinics of North America: Equine Practice"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.cveq.2023.06.007","type":"journal-article","created":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T15:24:08Z","timestamp":1691249048000},"page":"429-442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Equine Platelet-Rich Plasma"],"prefix":"10.1016","volume":"39","author":[{"given":"Taralyn M.","family":"McCarrel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.cveq.2023.06.007_bib1","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s40279-014-0195-5","article-title":"Considerations for the use of platelet-rich plasma in orthopedics","volume":"44","author":"McCarrel","year":"2014","journal-title":"Sports Med"},{"issue":"3","key":"10.1016\/j.cveq.2023.06.007_bib2","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.arthro.2018.10.125","article-title":"The Role of Platelet-Rich Plasma in Cartilage Pathology: An Updated Systematic Review of the Basic Science Evidence","volume":"35","author":"Fice","year":"2019","journal-title":"Arthroscopy"},{"issue":"10","key":"10.1016\/j.cveq.2023.06.007_bib3","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1007\/s11999-011-1857-3","article-title":"The role of growth factors in cartilage repair","volume":"469","author":"Fortier","year":"2011","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"10.1016\/j.cveq.2023.06.007_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1160\/TH03-07-0440","article-title":"Autologous platelets as a source of proteins for healing and tissue regeneration","volume":"91","author":"Anitua","year":"2004","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.cveq.2023.06.007_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.arthro.2011.10.018","article-title":"Platelet-rich plasma: a milieu of bioactive factors","volume":"28","author":"Boswell","year":"2012","journal-title":"Arthroscopy"},{"issue":"19","key":"10.1016\/j.cveq.2023.06.007_bib6","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.L.00019","article-title":"Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy","volume":"94","author":"McCarrel","year":"2012","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"1","key":"10.1016\/j.cveq.2023.06.007_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/0363546513507566","article-title":"Increasing platelet concentrations in leukocyte-reduced platelet-rich plasma decrease collagen gene synthesis in tendons","volume":"42","author":"Boswell","year":"2014","journal-title":"Am J Sports Med"},{"issue":"3","key":"10.1016\/j.cveq.2023.06.007_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121713","article-title":"Leukocyte Inclusion within a Platelet Rich Plasma-Derived Fibrin Scaffold Stimulates a More Pro-Inflammatory Environment and Alters Fibrin Properties","volume":"10","author":"Anitua","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cveq.2023.06.007_bib9","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/jbm.a.35244","article-title":"Morphogen and proinflammatory cytokine release kinetics from PRGF-Endoret fibrin scaffolds: Evaluation of the effect of leukocyte inclusion","volume":"103","author":"Anitua","year":"2015","journal-title":"J\u00a0Biomed Mater Res"},{"issue":"2","key":"10.1016\/j.cveq.2023.06.007_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-2184.2009.00583.x","article-title":"Fibroblastic response to treatment with different preparations rich in growth factors","volume":"42","author":"Anitua","year":"2009","journal-title":"Cell Prolif"},{"issue":"8","key":"10.1016\/j.cveq.2023.06.007_bib11","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/jor.22360","article-title":"Effect of platelet-rich plasma on the biologic activity of the human rotator-cuff fibroblasts: A controlled in\u00a0vitro study","volume":"31","author":"Sadoghi","year":"2013","journal-title":"J\u00a0Orthop Res"},{"issue":"3","key":"10.1016\/j.cveq.2023.06.007_bib12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tibtech.2008.11.009","article-title":"Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)","volume":"27","author":"Dohan Ehrenfest","year":"2009","journal-title":"Trends Biotechnol"},{"issue":"12","key":"10.1016\/j.cveq.2023.06.007_bib13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2217\/rme-2022-0118","article-title":"Platelet-rich plasma: are the obtaining methods, classification and clinical outcome always connected?","volume":"17","author":"Anitua","year":"2022","journal-title":"Regen Med"},{"issue":"3","key":"10.1016\/j.cveq.2023.06.007_bib14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/evj.12288","article-title":"Equine autologous platelet concentrates: A comparative study between different available systems","volume":"47","author":"Hessel","year":"2015","journal-title":"Equine Vet J"},{"issue":"1","key":"10.1016\/j.cveq.2023.06.007_bib15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12917-019-2040-4","article-title":"The effect of four different freezing conditions and time in frozen storage on the concentration of commonly measured growth factors and enzymes in equine platelet-rich plasma over six months","volume":"15","author":"McClain","year":"2019","journal-title":"BMC Vet Res"},{"issue":"2","key":"10.1016\/j.cveq.2023.06.007_bib16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jor.20278","article-title":"Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons","volume":"25","author":"Schnabel","year":"2007","journal-title":"J\u00a0Orthop Res"},{"issue":"6","key":"10.1016\/j.cveq.2023.06.007_bib17","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/jor.24584","article-title":"Platelet-rich plasma lysate displays antibiofilm properties and restores antimicrobial activity against synovial fluid biofilms in\u00a0vitro","volume":"38","author":"Gilbertie","year":"2020","journal-title":"J\u00a0Orthop Res"},{"issue":"9\u201310","key":"10.1016\/j.cveq.2023.06.007_bib18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1089\/ten.tea.2020.0160","article-title":"Washed Equine Platelet Extract as an Anti-Inflammatory Biologic Pharmaceutical","volume":"27","author":"Pennati","year":"2021","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.cveq.2023.06.007_bib19","doi-asserted-by":"crossref","first-page":"579967","DOI":"10.3389\/fvets.2020.579967","article-title":"A\u00a0Survey of Clinical Usage of Non-steroidal Intra-Articular Therapeutics by Equine Practitioners","volume":"7","author":"Velloso Alvarez","year":"2020","journal-title":"Front Vet Sci"},{"issue":"4","key":"10.1016\/j.cveq.2023.06.007_bib20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/vsu.13805","article-title":"Current use of biologic therapies for musculoskeletal disease: A survey of board-certified equine specialists","volume":"51","author":"Knott","year":"2022","journal-title":"Vet Surg"},{"issue":"3","key":"10.1016\/j.cveq.2023.06.007_bib21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2746\/042516408X278030","article-title":"Effects of platelet rich plasma and acellular bone marrow on gene expression patterns and DNA content of equine suspensory ligament explant cultures","volume":"40","author":"Schnabel","year":"2008","journal-title":"Equine Vet J"},{"issue":"8","key":"10.1016\/j.cveq.2023.06.007_bib22","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/jor.20853","article-title":"Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression","volume":"27","author":"McCarrel","year":"2009","journal-title":"J\u00a0Orthop Res"},{"issue":"2","key":"10.1016\/j.cveq.2023.06.007_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/jor.20980","article-title":"Effects of platelet-rich plasma on the quality of repair of mechanically induced core lesions in equine superficial digital flexor tendons: A placebo-controlled experimental study","volume":"28","author":"Bosch","year":"2010","journal-title":"J\u00a0Orthop Res"},{"issue":"4","key":"10.1016\/j.cveq.2023.06.007_bib24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1600-0838.2009.01070.x","article-title":"The effect of platelet-rich plasma on the neovascularization of surgically created equine superficial digital flexor tendon lesions","volume":"21","author":"Bosch","year":"2011","journal-title":"Scand J Med Sci Sports"},{"issue":"1","key":"10.1016\/j.cveq.2023.06.007_bib25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tvjl.2009.10.014","article-title":"Computerised analysis of standardised ultrasonographic images to monitor the repair of surgically created core lesions in equine superficial digital flexor tendons following treatment with intratendinous platelet rich plasma or placebo","volume":"187","author":"Bosch","year":"2011","journal-title":"Vet J"},{"issue":"38","key":"10.1016\/j.cveq.2023.06.007_bib26","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.2042-3306.2010.00175.x","article-title":"Mechanical properties of the equine superficial digital flexor tendon relate to specific collagen cross-link levels","author":"Thorpe","year":"2010","journal-title":"Equine Vet J Suppl"},{"issue":"6","key":"10.1016\/j.cveq.2023.06.007_bib27","first-page":"1119","article-title":"Regenerative medicine for the treatment of Teno-desmic injuries of the equine. A series of 150 horses treated with platelet-derived growth factors","volume":"28","author":"Scala","year":"2014","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.cveq.2023.06.007_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.tvjl.2016.08.003","article-title":"Comparison of treatment outcomes for superficial digital flexor tendonitis in National Hunt racehorses","volume":"216","author":"Witte","year":"2016","journal-title":"Vet J"},{"issue":"10","key":"10.1016\/j.cveq.2023.06.007_bib29","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2460\/javma.232.10.1515","article-title":"Intralesional injection of platelet-rich plasma followed by controlled exercise for treatment of midbody suspensory ligament desmitis in Standardbred racehorses","volume":"232","author":"Waselau","year":"2008","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"1","key":"10.1016\/j.cveq.2023.06.007_bib30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2460\/javma.243.1.120","volume":"243","author":"Garrett","year":"2013","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2023.06.007_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.rvsc.2019.07.020","article-title":"Prospective randomized comparison of platelet rich plasma to extracorporeal shockwave therapy for treatment of proximal suspensory pain in western performance horses","volume":"126","author":"Giunta","year":"2019","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.cveq.2023.06.007_bib32","doi-asserted-by":"crossref","first-page":"678453","DOI":"10.3389\/fvets.2021.678453","article-title":"Effectiveness of Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate as Treatments for Chronic Hindlimb Proximal Suspensory Desmopathy","volume":"8","author":"Maleas","year":"2021","journal-title":"Front Vet Sci"},{"issue":"1","key":"10.1016\/j.cveq.2023.06.007_bib33","first-page":"37","article-title":"The Use of Platelet-Rich Plasma in Symptomatic Knee Osteoarthritis","volume":"32","author":"Southworth","year":"2019","journal-title":"J\u00a0Knee Surg"},{"issue":"5","key":"10.1016\/j.cveq.2023.06.007_bib34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1532-950X.2013.12015.x","article-title":"Intra-articular use of a platelet-rich product in normal horses: clinical signs and cytologic responses","volume":"42","author":"Textor","year":"2013","journal-title":"Vet Surg"},{"key":"10.1016\/j.cveq.2023.06.007_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fvets.2016.00029","article-title":"Gait Changes Vary among Horses with Naturally Occurring Osteoarthritis Following Intra-articular Administration of Autologous Platelet-Rich Plasma","volume":"3","author":"Mirza","year":"2016","journal-title":"Front Vet Sci"},{"issue":"0","key":"10.1016\/j.cveq.2023.06.007_bib36","first-page":"e1","article-title":"Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis","volume":"90","author":"Smit","year":"2019","journal-title":"J\u00a0S Afr Vet Assoc"},{"key":"10.1016\/j.cveq.2023.06.007_bib37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.rvsc.2020.08.017","article-title":"Platelet lysate reduces the chondrocyte dedifferentiation during in\u00a0vitro expansion: Implications for cartilage tissue engineering","volume":"133","author":"De Angelis","year":"2020","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.cveq.2023.06.007_bib38","doi-asserted-by":"crossref","first-page":"102952","DOI":"10.1016\/j.jevs.2020.102952","article-title":"Treatment With Platelet Lysate Inhibits Proteases of Synovial Fluid in Equines With Osteoarthritis","volume":"88","author":"Perrone","year":"2020","journal-title":"J\u00a0Equine Vet Sci"},{"key":"10.1016\/j.cveq.2023.06.007_bib39","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fvets.2018.00150","article-title":"Pooled Platelet-Rich Plasma Lysate Therapy Increases Synoviocyte Proliferation and Hyaluronic Acid Production While Protecting Chondrocytes From Synoviocyte-Derived Inflammatory Mediators","volume":"5","author":"Gilbertie","year":"2018","journal-title":"Front Vet Sci"},{"issue":"1","key":"10.1016\/j.cveq.2023.06.007_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12917-022-03225-4","article-title":"A\u00a0safety evaluation of allogeneic freeze-dried platelet-rich plasma or conditioned serum compared to autologous frozen products equivalents in equine healthy joints","volume":"18","author":"Garbin","year":"2022","journal-title":"BMC Vet Res"},{"issue":"3","key":"10.1016\/j.cveq.2023.06.007_bib41","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/vsu.13784","article-title":"Arthroscopic findings and long-term outcomes in 76 sport horses with meniscal injuries (2008-2018)","volume":"51","author":"Davis","year":"2022","journal-title":"Vet Surg"},{"issue":"7","key":"10.1016\/j.cveq.2023.06.007_bib42","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1532-950X.2012.01016.x","article-title":"Activation of equine platelet-rich plasma: comparison of methods and characterization of equine autologous thrombin","volume":"41","author":"Textor","year":"2012","journal-title":"Vet Surg"},{"key":"10.1016\/j.cveq.2023.06.007_bib43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fvets.2017.00205","article-title":"Extracorporeal Shockwave Therapy Increases Growth Factor Release from Equine Platelet-Rich Plasma In\u00a0Vitro","volume":"4","author":"Seabaugh","year":"2017","journal-title":"Front Vet Sci"},{"issue":"10","key":"10.1016\/j.cveq.2023.06.007_bib44","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1292\/jvms.20-0167","article-title":"Optimal activation methods for maximizing the concentrations of platelet-derived growth factor-BB and transforming growth factor-beta 1 in equine platelet-rich plasma","volume":"82","author":"Fukuda","year":"2020","journal-title":"J\u00a0Vet Med Sci"},{"issue":"4","key":"10.1016\/j.cveq.2023.06.007_bib45","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2125.2011.03943.x","article-title":"Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy","volume":"72","author":"Warner","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.cveq.2023.06.007_bib46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1054\/plef.2001.0276","article-title":"Do human platelets express COX-2?","volume":"64","author":"Reiter","year":"2001","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"5","key":"10.1016\/j.cveq.2023.06.007_bib47","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2885.1994.tb00262.x","article-title":"The effects of aspirin and paracetamol on the aggregation of equine blood platelets","volume":"17","author":"Heath","year":"1994","journal-title":"J\u00a0Vet Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.cveq.2023.06.007_bib48","doi-asserted-by":"crossref","DOI":"10.1177\/2325967115588896","article-title":"Autologous Platelet-Rich Plasma Preparations: Influence of Nonsteroidal Anti-inflammatory Drugs on Platelet Function","volume":"3","author":"Schippinger","year":"2015","journal-title":"Orthop J Sports Med"},{"issue":"14","key":"10.1016\/j.cveq.2023.06.007_bib49","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1177\/0363546517730578","article-title":"Use of a Cyclooxygenase-2 Inhibitor Does Not Inhibit Platelet Activation or Growth Factor Release From Platelet-Rich Plasma","volume":"45","author":"Ludwig","year":"2017","journal-title":"Am J Sports Med"},{"key":"10.1016\/j.cveq.2023.06.007_bib50","unstructured":"McCarrel TM, Beatty SSK, Merrill KA, Doty A. The effect of commonly used NSAIDs on platelet function in PRP. Paper presented at: 2020 ACVS Surgery Summit; 15 September 2020, 2020; Virtual conference. The meeting was supposed to be held October 21-24, 2020 in Washington, DC."},{"issue":"5","key":"10.1016\/j.cveq.2023.06.007_bib51","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/516120","article-title":"The role of platelets in antimicrobial host defense","volume":"25","author":"Yeaman","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.cveq.2023.06.007_bib52","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1128\/iai.65.3.1023-1031.1997","article-title":"Purification and in\u00a0vitro activities of rabbit platelet microbicidal proteins","volume":"65","author":"Yeaman","year":"1997","journal-title":"Infect Immun"},{"issue":"3\u20134","key":"10.1016\/j.cveq.2023.06.007_bib53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.vetimm.2012.12.007","article-title":"Equine platelets inhibit E. coli growth and can be activated by bacterial lipopolysaccharide and lipoteichoic acid although superoxide anion production does not occur and platelet activation is not associated with enhanced production by neutrophils","volume":"152","author":"Aktan","year":"2013","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.cveq.2023.06.007_bib54","doi-asserted-by":"crossref","first-page":"895022","DOI":"10.3389\/fcimb.2022.895022","article-title":"A\u00a0Platelet-Rich Plasma-Derived Biologic Clears Staphylococcus aureus Biofilms While Mitigating Cartilage Degeneration and Joint Inflammation in a Clinically Relevant Large Animal Infectious Arthritis Model","volume":"12","author":"Gilbertie","year":"2022","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Veterinary Clinics of North America: Equine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749073923000469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749073923000469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:21:10Z","timestamp":1760070070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749073923000469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0749073923000469"],"URL":"https:\/\/doi.org\/10.1016\/j.cveq.2023.06.007","relation":{},"ISSN":["0749-0739"],"issn-type":[{"value":"0749-0739","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Equine Platelet-Rich Plasma","name":"articletitle","label":"Article Title"},{"value":"Veterinary Clinics of North America: Equine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cveq.2023.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}